A placenta cell medication could help the U.S. get through a nuclear meltdown
July 13, 2017 at 08:05 AM EDT
Developed by the Israeli biotech Pluristem, the injection aims to help body tissue that’s been damaged by radiation.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.